Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines

Patients with HPV-positive head and neck squamous cell carcinoma (HNSCC) show better survival rates than those with HPV-negative HNSCC. While an enhanced radiosensitivity of HPV-positive tumors is clearly evident from single modality treatment, cisplatin is never administered as monotherapy and ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Busch, Chia-Jung, Becker, Benjamin, Kriegs, Malte, Gatzemeier, Fruzsina, Krüger, Katharina, Möckelmann, Nikolaus, Fritz, Gerhard, Petersen, Cordula, Knecht, Rainald, Rothkamm, Kai, Rieckmann, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094966/
https://www.ncbi.nlm.nih.gov/pubmed/27127883
http://dx.doi.org/10.18632/oncotarget.9028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094966/
https://www.ncbi.nlm.nih.gov/pubmed/27127883
http://dx.doi.org/10.18632/oncotarget.9028

Ejemplares similares